PVLA
Palvella Therapeutics, Inc
NASDAQ: PVLA · HEALTHCARE · BIOTECHNOLOGY
$130.17
+0.54% today
Updated 2026-05-06
Market cap
$1.82B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.70
Dividend yield
—
52W range
$20 – $151
Volume
0.3M
Palvella Therapeutics, Inc (PVLA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |